How do you pay?

How to pay the least

Ask for the cash price

Bomyntra

Bomyntra is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Bomyntra’s cash price, and one or two other pharmacies too.

Compare every option

Question
Brand nameBomyntra
Authorized genericdenosumab
Regular genericdenosumab
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Bomyntra?
The original
–
–

Brand nameNo maker’s card

We didn’t find a savings card or cash price from Bomyntra’s maker. Ask the pharmacy for Bomyntra’s cash price. With insurance, ask what your plan charges.

Authorized genericNot sold

There isn’t one. An authorized generic is Bomyntra itself, from the same company, sold without the brand name, and usually for less. For now Bomyntra is the only choice; ask the pharmacy for its cash price, or your plan what it charges.

Regular genericNot sold

Bomyntra is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, ask the pharmacy for Bomyntra’s cash price, or your plan what it charges.

What it’s used for

What the FDA label says

Bomyntra is a RANK ligand (RANKL) inhibitor indicated for:

  • Prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors.
  • Treatment of adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity.
  • Treatment of hypercalcemia of malignancy refractory to bisphosphonate therapy.

Source: the FDA label for Bomyntra (Fresenius Kabi USA, LLC), March 31, 2025. Full label on DailyMed 

Good to know